Nanostructured lipid system as a strategy to improve the anti-Candida albicans activity of Astronium sp

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 5081-5092

  Bonifácio, Bruna Vidal ^a   dos Santos Ramos, Matheus Aparecido ^a   da Silva, Patrícia Bento ^b   Negri, Kamila Maria Silveira ^a   de Oliveira Lopes, Érica ^a   de Souza, Leonardo Perez ^c   Vilegas, Wagner ^c   Pavan, Fernando Rogério ^a   Chorilli, Marlus ^b   Bauab, Taís Maria ^a  

^a Department of Biological Sciences ^*  (Brazil)

^b School of Pharmaceutical Sciences   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Anticandidal activity; Microdilution; Microemulsion; Plant extract; Vulvovaginal candidiasis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B PLUS TETRACYCLINE; ANTIFUNGAL AGENT; ASTRONIUM FRAXINIFOLIUM EXTRACT; ASTRONIUM GRAVEOLENS EXTRACT; ASTRONIUM URUNDEUVA EXTRACT; CHOLESTEROL; FLUCONAZOLE; OLEATE SODIUM; PHOSPHATIDYLCHOLINE; PLANT EXTRACT; POLYSORBATE 20; SOYBEAN PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG; LIPID; NANOPARTICLE;

ANACARDIACEAE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; ASTRONIUM FRAXINIFOLIUM; ASTRONIUM GRAVEOLENS; ASTRONIUM URUNDEUVA; BIOADHESION ASSAY; BIOASSAY; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG POTENTIATION; DRUG SCREENING; DRUG SELECTIVITY; FEMALE; IC50; IN VITRO STUDY; IN VIVO STUDY; LIGHT SCATTERING; MICROEMULSION; MINIMUM INHIBITORY CONCENTRATION; NANOSTRUCTURED LIPID SYSTEM; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PHARMACOLOGICAL PARAMETERS; PLANT LEAF; PLANT STEM; RAT; SELECTIVITY INDEX; TRANSMISSION ELECTRON MICROSCOPY; VAGINA CANDIDIASIS; VERO CELL LINE; X RAY DIFFRACTION; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST;

ANACARDIACEAE; ASTRONIUM; ASTRONIUM FRAXINIFOLIUM; ASTRONIUM GRAVEOLENS; ASTRONIUM URUNDEUVA; CANDIDA ALBICANS;

ANACARDIACEAE; CANDIDA ALBICANS; LIPIDS; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; PLANT EXTRACTS;

EID: 84939856438     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S79684     Document Type: Article

References (49)

1. Barbedo LS, Sgarbi DBC. Candidiasis. J Bras Doenças Sex Transm. 2010;22(1):22-38.
2. Araújo MGF, Pacífico M, Vilegas W, et al. Evaluation of Syngonanthus nitens (Bong.) Ruhl. extract as antifungal and in treatment of vulvovaginal candidiasis. Med Mycol. 2013;51(7):673-682.
3. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23(2):253-273.
4. Morales GI, Yaneth MC. Candidiasis in reproductive age women attending the Eduardo Arredondo Daza hospital in the city of Valledupar. RCMT. 2012;22(2):13-21.
5. Repentigny L. Animal models in the analysis of Candida host-pathogen interactions. Curr Opin Microbiol. 2004;7(4):324-329.
6. Barbosa C, Fernandes G, Quintas C, Ester Teixeira M, Pedro Neves J. Anti-fungal treatment with azole compounds for uncomplicated vulvovaginal candidiasis. Acta Obstet Ginecol Port. 2012;6(3):118-123.
7. Barai L, Fatema K, Haq JA, et al. Bacterial profile and their antimicrobial resistance pattern in an intensive care unit of a tertiary care hospital in Dhaka. Ibrahim Med Coll. 2010;4(2):66-69.
8. Aguiar AV, Bortolozo FR, Moraes MLT, Andrade JAC. Genetic variation in Astronium fraxinifolium populations in consortium. Crop Breed Appl Biotechnol. 2003;3(2):95-106.
9. Luna CV. Distribution and importance of the family Anacardiaceae timber in the gran chaco of Argentina. Ra Ximhai. 2012;8(3):83-95.
10. Cunha FP, Costa LJL, Fernandes AJD, Souza TP, Soares LAL. Development and optimization of extractives from Astronium urundeuva (allemão) Engl. by factorial design. Braz Arch Biol Technol. 2009;52(3): 647-652.
11. Carlini EA, Duarte-Almeida JM, Rodrigues E, Tabach R. Antiulcer effect of the pepper trees Schinus terebinthifolius Raddi (aroeira-da-praia) and Myracrodruon urundeuva Allemão, Anacardiaceae (aroeira-do-sertão). Rev Bras Farmacogn. 2010;20(2):140-146.
12. Silva PB, Ramos MAS, Bonifácio BV, et al. Nanotechnological strategies for vaginal administration of drugs-a review. J Biomed Nanotechnol. 2014;10(9):2218-2243.
13. Wang Y, Zhang L, Wang Q, Zhang D. Recent advances in the nanotechnology-based drug delivery of silybin. J Biomed Nanotechnol. 2014; 10(4):543-558.
14. Bonifácio BV, Silva PB, Ramos MAS, Negri KMS, Bauab TM, Chorilli M. Nanotechnology-based drug delivery systems and herbal medicines-a review. Int J Nanomedicine. 2014;9:1-15.
15. Ezrahi S, Aserin A, Garti N, Berkovic G. An excursion into phase tetrahedra-where physical chemistry and geometry meet. J Chem Educ. 1998;75(12):1648-1652.
16. Kovarik JM, Mueller EA, Van Bree JB, Tetzloff W, Kutz K. Reduced inter and intra intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J Pharm Sci. 1994;83(3): 444-446.
17. Damasceno BP, Dominici VA, Urbano IA, et al. Amphotericin B microemulsion reduces toxicity and maintains the efficacy as an antifungal product. J Biomed Nanotechnol. 2012;8(2):290-300.
18. Franzini CM, Pestana KC, Molina EF, Scarpa MV, Egito ES, Oliveira AG. Structural properties induced by the composition of biocompatible phospholipid-based microemulsion and amphotericin B association. J Biomed Nanotechnol. 2012;8(2):350-359.
19. D’Cruz OJ, Yiv H, Waurzyniak B, Uckun FM. Contraceptive efficacy and safety studies of a novel microemulsion-based lipophilic vaginal spermicide. Fertil Steril. 2001;75(1):115-124.
20. Oliveira MB, Calixto G, Graminha M, Cerecetto H, Gonzáles M, Chorilli M. Development, characterization, and in vitro biological performance of fluconazole-loaded microemulsions for the topical treatment of cutaneous leishmaniasis. Biomed Res Int. 2015;2015:396894.
21. Silveira WLL, Damasceno BPGL, Silva KGH, Oliveira AG, Egito EST. Aspectos fundamentais no desenvolvimento de sistemas microemulsionados contendo anfotericina B para uso oftálmico [Fundamental aspects in the development of microemulsion systems containing amphotericin B for ophthalmic use]. Rev Ciênc Farm Básica Apl. 2013;34(1):9-15.
22. Silva GBRF, Scarpa MV, Rossanezi G, Egito EST, Oliveira AG. Development and characterization of biocompatible isotropic and anisotropic oil-in-water colloidal dispersions as a new delivery system for methyl dihydrojasmonate antitumor drug. Int J Nanomedicine. 2014;9: 867-876.
23. Assumpção JUC, Campos ML, Filho MAFN, et al. Biocompatible microemulsion modifies the pharmacokinetic profile and cardiotoxicity of doxorubicin. J Pharm Sci. 2013;102(1):289-296.
24. Sato MR, Silva PB, Souza RA, Santos KC, Chorilli M. Recent advances in nanoparticle carriers for coordination complexes. Curr Top Med Chem. 2015;15(4):287-297.
25. Simões CMO, Schenkel EP, Gosmann G, Mello JCP, Mentz LA, Pedrovick PR. Farmacognosia: da planta ao medicamento [Pharmacognosy: from the Plant to the Drug]. Porto Alegre: UFRGS; 2010. [Portuguese].
26. Clinical and Laboratory Standards Institute. Reference Methods for Broth Dilution Antifungal Susceptibility Tests for Yeasts; Approved Standards. Wayne, PA: Clinical and Laboratory Standards Institute; 2008. [CLSI document (M27-A3)].
27. Duarte MCT, Figueira GM, Sartoratto A, Rehder VLG, Delarmelina C. Anti-Candida activity of Brazilian medicinal plants. J Ethnofarmacol. 2005;97(2):305-311.
28. Zanin SMW, Miguel MD, Chimelli MC, Oliveira AB. Hydrophile-lipophile balance (HLB) determination of vegetable oil family. Vis Acad. 2002;3(1):13-18.
29. Calixto G, Yoshii AC, Rocha eSilva H, Cury BSF, Chorilli M. Polyacrylic acid polymers hydrogels intended to topical drug delivery: preparation and characterization. Pharm Dev Technol. 2014;19: 1-7.
30. Carvalho FC, Calixto G, Hatakeyama IN, Luz GM, Gremião MP, Chorilli M. Rheological, mechanical, and bioadhesive behavior of hydrogels to optimize skin delivery systems. Drug Dev Ind Pharm. 2013; 39(11):1750-1757.
31. Santos FK, Oyafuso MH, Kiill CP, Gremião MPD, Chorilli M. Nanotechnology-based drug delivery systems for treatment of hyperproliferative skin diseases-a review. Curr Nanosci. 2013;9(1):159-167.
32. Pavan FR, Maia PIS, Leite SRA, et al. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity. Eur J Med Chem. 2010;45(5):1898-1905.
33. Orme I. Search for new drugs for treatment of tuberculosis. Antimicrob Agents Chemother. 2001;45(7):1943-1946.
34. Yano J, Kolls JK, Happel KI, Wormley F, Wozniak KL, Fidel PLJ. The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17-pathway. PLoS One. 2012;7(9):e46311.
35. Yano J Jr, Fidel PL. Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitis. J Vis Exp. 2011;8(58):3382.
36. Orthaber D, Glatter O. Synthetic phospholipid analogs: a structural investigation with scattering methods. Phys Lipids. 2000;107(2):179-189.
37. Formariz TP, Urban CC, Silva Júnior AA, Gremião MPD, Oliveira AG. Microemulsion and liquid crystals as drug delivery systems. Rev Bras Cien Farm. 2005;41(3):301-331.
38. Tomsic M, Podlogar F, Gasperlin M, Bester-Rogac M, Jamnik A. Water-Tween 40®/Imwistor 308®-isopropyl myristate microemulsions as delivery systems for ketoprofen: small-angle X-ray scattering study. Int J Pharm. 2006;327:170-177.
39. Moghimipour E, Salimi A, Karami M, Isazadeh S. Preparation and characterization of dexamethasone microemulsion based on pseudoternary phase diagram. Jundishapur J Nat Pharm Prod. 2013;8(3): 105-112.
40. Silva RMG, Saraiva TS, Silva RB, Gonçalves LA, Silva LP. Allelopathy potential of etanolic extract of Anadenanthera macrocarpa and Astronium graveolens. J Biosci. 2010;26(4):632-637.
41. Newman DJ, Gragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75(3):311-335.
42. Rossi T, Brito JO, Bittencourt E, Almeida RSR, Faria PN, Dias CTS. Eucalyptus waste effluent as a natural dyestuff for dyeing cotton fabrics. Redige. 2012;3(1):1-12.
43. Das K, Tiwari RKS, Shrivastava DK. Techniques for evaluation of medicinal plant products as antimicrobial agent: current methods and future trends. J Med Plants Res. 2010;4(2):104-111.
44. Aligiannis N, Kalpoutzakis E, Mitaku S, Chinou IB. Composition and antimicrobial activity of the essential oils of two Origanum species. J Agric Food Chem. 2001;49(9):4168-4170.
45. Webster D, Taschereau P, Belland RJ, Sand C, Rennie RP. Antifungal activity of medicinal plant extracts preliminary screening studies. J Ethnopharmacol. 2008;115(1):140-146.
46. Missner A, Pohl P. 110 years of the Meyer-Overton rule: predicting membrane permeability of gases and other small compounds. Chemphyschem. 2009;10(9 10):1405-1414.
47. Cunha Júnior ASC, Fialho SL, Carneiro LB, Orefice F. Microemulsions as drug delivery systems for topical ocular administration. Arq Bras Oftalmol. 2003;66(3):385-391.
48. D’Cruz OJ, Uckun FM. Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles. Contraception. 2001;64(2):113-123.
49. Angelova A, Ionev R, Koch MHJ, Rapp G. Interaction of the peptide antibiotic alamethicin with bilayer and non-bilayer forming lipids: influence of increasing alamethicin concentration on the lipids supramolecular structures. Arch Biochem Biophys. 2000;378(1):93-106